519
Views
2
CrossRef citations to date
0
Altmetric
Articles

Statistical innovations in diagnostic device evaluation

, , &

References

  • Beam, C., Layde, P. M., Sullivan, D. C. (1996). Variability in the interpretation of screening mammograms by US radiologists. Archives of Internal Medicine 156:209–213.
  • Beiden, S. V., Wagner, R. F., Campbell, G. (2000). Components-of-variance models and multiple-bootstrap experiments: An alternative method for random-effects receiver operating characteristic analysis. Academic Radiology 7:341–349.
  • Campbell, G., Pennello, G., Yue, L. (2011). Missing data in the regulation of medical devices. Journal of Biopharmaceutical Statistics Impact 21(2):180–195.
  • Campbell, G., Yue, Q. L. (2016). Statistical innovations in the medical device world sparked by the FDA. Journal of Biopharmaceutical Statistics 26(1):3–16. doi:10.1080/10543406.2015.1092037.
  • Chow, S. C., Chang, M. (2006). Adaptive Design Methods in Clinical Trials. New York, NY: Chapman and Hall/CRC Press, Taylor and Francis.
  • CLSI. Method Comparison and Bias Estimation Using Patient Samples; Approved guideline – second edition. CLSI EP09-A3.
  • CLSI. Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline—Second Edition. CLSI I/LA28-A2.
  • CLSI. User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline – Second Edition. CLSI EP12-A2.
  • Denne, J., G. Pennello, L. Zhao, S. C. Chang, S. Althouse (2014). Identifying a subpopulation for a tailored therapy: Bridging clinical efficacy from a laboratory-developed assay to a validated in vitro diagnostic test kit. Statistics in Biopharmaceutical Research 6(1):78–88.
  • Dorfman, D. D., Berbaum, K. S., Metz, C. E. (1992). Receiver operating characteristic rating analysis: Generalization to the population of readers and patients with the jackknife method. Investigative Radiology 27:723–731.
  • Efron, B., Tibshirani, R. J. (1993). An introduction to the bootstrap. In Monographs on Statistics and Applied Probability, 57. New York, NY: Chapman & Hall.
  • FDA. (2007). Guidance for Industry and FDA Staff. Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests. URL http://www.fda.gov/RegulatoryInformation/Guidances/ucm071148.htm
  • FDA. (2010). Guidance for Industry. Adaptive Design Clinical Trials for Drugs and Biologics. URL http://www.fda.gov/downloads/Drugs/…/Guidances/ucm201790.pdf.
  • FDA. (2013a). Design Considerations for Pivotal Clinical Investigations for Medical Devices – Guidance for Industry, Clinical Investigators, Institutional Review Boards and Food and Drug Administration Staff.
  • FDA. (2013b). Paving the Way for Personalized Medicine. FDA’s Role in a New Era of Medical Product Development.
  • FDA. (2014). Guidance for Industry and Food and Drug Administration Staff - in vitro Companion Diagnostic Devices. URL http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm262327.pdf
  • FDA. (2015). Adaptive Designs for Medical Device Clinical Studies: Draft Guidance for Industry and Food and Drug Administration Staff. URL http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM446729.pdf.
  • Gallas, B. D., et al. (2012). Evaluating imaging and computer-aided detection and diagnosis devices at the FDA. Academic Radiology 19:463–477.
  • Hillis, S. L., Obuchowski, N. A., Schartz, K. M., et al. (2005). A comparison of the Dorfman-Berbaum-Metz and Obuchowski-Rockette methods for receiver operating characteristic (ROC) data. Statistics in Medicine 24:1579–1607.
  • Li, M. (2015). Statistical consideration and challenges in bridging study of personalized medicine. Journal of Biopharmaceutical Statistics 25:397–407.
  • Li, M., Yu, T., Hu, Y.-F. (2015). The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine. Statistics in Medicine. doi:10.1002/sim6476.
  • Li, M. (2016). Statistical methods for clinical validation of follow-on companion diagnostic devices via an external concordance study. Journal of Biopharmaceutical Statistics doi:10.1080/19466315.2016.1202859.
  • Pennello, G. (2013). Analytical and clinical evaluation of biomarkers assays: When are biomarkers ready for prime time? Clinical Trials 10:666–676.
  • Liang, K. Y., Zeger, S. L. (1992). Regression analysis for correlated data. Annual Review of Public Health 14:43–68.
  • Liang, K. Y., Zeger, S. L., Qaqish, B. (1992). Multivariate regression analysis for categorical data. Journal of the Royal Statistical Society B 54:3–24.
  • Linnet, K. (1993). Evaluation of regression procedures for methods comparison studies. Clinical Chemistry 39(3):424–432.
  • Little, R. J. A., Rubin, D. B. (2002). Statistical Analysis with Missing Data, 2nd ed. New York, NY: Wiley & Sons.
  • Obuchowski, N. A. (1995). Multi-reader ROC studies: A comparison of study designs. Academic Radiology 2:709–716.
  • Obuchowski, N. A., Beiden S. V., Berbaum, K. S., Hillis, S. L., Ishwaran, H., Song, H. H., Wagner, R. F. (2004). Multireader, multicase receiver operating characteristic analysis: an empirical comparison of five methods. Academic Radiology 11:890–995.
  • Obuchowski, N. A., Meziane, M., Dachman, A. H., et al. (2010). What’s the control in studies measuring the effect of computer-aided detection (CAD) on observer performance? Academic Radiology 17:761–767.
  • Obuchowski, N. A., Rockette, H. E. (1995). Hypothesis testing of the diagnostic accuracy for multiple diagnostic tests: An ANOVA approach with dependent observations. Communications in Statistics-Simulation and Computation 24:285–308.
  • Pepe, M. S. (2003). The Statistical Evaluation of Medical Tests for Classification and Prediction. New York, NY: Oxford University Press.
  • Rubin, D. (1996). Multiple imputation after 18+ years. Journal of the American Statistical Association 91(434):473–489.
  • Sargent, D., Conley, B., Allegra, C., Collette, L. (2005). Clinical trial designs for predictive marker validation in cancer treatment trials. Journal of Clinical Oncology 23:2020–2027.
  • Shao, J., Tu, D. (1995). The Jackknife and Bootstrap. New York, NY: Springer-Verlag.
  • Tan, C. S., Gilligan, D., Pacey, S. (2015). Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer. The Lancet Oncology 16(9):e447–e459.
  • Wagner, R. F., Metz, C. E., Campbell, G. (2007). Assessment of medical imaging systems and computer aids: A tutorial review. Academic Radiology 14:723–748.
  • Wang, S.-J. (2007). Biomarker as a classifier in pharmacogenomics clinical trials: A tribute to 30th anniversary of PSI. Pharmaceutical Statistics 6:283–296.
  • Young, K. Y., Laird, A., Zhou, X. H. (2010). The efficiency of clinical trial designs for predictive biomarker validation. Clinical Trials 7:557–566.
  • Yu, T., Mai, Y., Liu, S., Hu, X. (2015). Combining survival trials using aggregate data based on mis-specified models. Midwest Biopharmaceutical Statistics Workshop, 2015.
  • Zhou, X. H., Obuchowski, N. A., McClish, D. K. (2011). Statistical Methods in Diagnostic Medicine, 2nd ed. New York, NY: Wiley.
  • Zweig, M. H., Campbell, G. (1993). Receiver operating characteristic plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry 39:561–577.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.